JOHNSON & JOHNSON Q2 2025 Filing
Filed July 22, 2025
Portfolio Value
$334.1B
Holdings
20
Report Date
Q2 2025
Filing Type
13F-HR
All Holdings (20 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | PTGXProtagonist Therapeutics Inc. | 2,449,183 | $136.4B | 40.83% | |
| 2 | MGTXMeiraGTx Holdings plc | 6,641,064 | $43.9B | 13.14% | |
| 3 | RAPPRapport Therapeutics, Inc. | 2,498,051 | $28.6B | 8.55% | |
| 4 | LEGNLegend Biotech Corporation | 814,586 | $28.2B | 8.44% | |
| 5 | NBTXNanobiotix S.A. | 5,623,816 | $25.5B | 7.62% | |
| 6 | CVRXCVRx, Inc. | 4,103,430 | $23.9B | 7.15% | |
| 7 | PRCTProcept BioRobotics Corporation | 357,939 | $20.4B | 6.10% | |
| 8 | CTNMContineum Therapeutics Inc. | 1,979,173 | $8.1B | 2.43% | |
| 9 | XNCRXencor, Inc. | 748,062 | $6.1B | 1.82% | |
| 10 | ARWRArrowhead Pharmaceuticals, Inc. | 247,598 | $4.0B | 1.19% | |
| 11 | FATEFate Therapeutics, Inc. | 3,379,064 | $3.5B | 1.05% | |
| 12 | NMRANeumora Therapeutics, Inc. | 1,849,445 | $1.4B | 0.42% | |
| 13 | RLYBRallybio Corporation | 3,636,363 | $1.2B | 0.36% | |
| 14 | VORVor Biopharma, Inc. | 1,074,658 | $1.1B | 0.34% | |
| 15 | NNOXNano-X Imaging Ltd. | 158,852 | $830.8M | 0.25% | |
| 16 | FLBStandard BioTools Inc | 311,967 | $371.2M | 0.11% | |
| 17 | LYELLyell Immunopharma Inc. | 41,165 | $368.0M | 0.11% | |
| 18 | TORCEURAdicet Bio, Inc. | 364,472 | $228.0M | 0.07% | |
| 19 | PHGEBiomX Inc. | 96,866 | $42.6M | 0.01% | |
| 20 | SENS1GBPSenseonics Holdings, Inc. | 54,621 | $27.0M | 0.01% |